Clinical trial
Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing…
NCT00093184 · The Medicines Company, Industry · Completed
Key facts
| NCT number | NCT00093184 |
|---|---|
| Title | Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI |
| Official title | A Study Evaluating the Safety and Efficacy of Bivalirudin in the Management of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary PCI (BIAMI) |
| Lead sponsor | The Medicines Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Angiomax (bivalirudin) anticoagulant |
| Enrollment | 300 |
| Start date | Apr 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Oct 7, 2004 |
| Last update posted | Feb 9, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: